期刊文献+

HE4基因表达载体的构建及对卵巢癌细胞HO8910生长侵袭的影响 被引量:3

Effect of HE4 Overexpression on the Proliferation and Invasion Abilities of the Ovarian Cancer Cell Line HO8910
原文传递
导出
摘要 目的探讨卵巢癌基因HE4对卵巢癌细胞增殖及侵袭能力的影响。方法构建针对HE4基因的PcDNA3.1/HE4载体,脂质体法介导PcDNA3.1/HE4载体转染人浆液性卵巢癌细胞系HO8910,WESTERN-BLOT检测转染前后细胞内HE4蛋白的表达效果。用四甲基偶氮唑蓝(MTT)比色法、平板克隆形成实验观察HE4基因对细胞增殖能力的影响,经细胞粘附实验、体外侵袭力实验比较转染前后细胞侵袭能力的变化。结果Western-blot结果显示PcDNA3.1/HE4载体成功转染HO8910细胞并显著提高该细胞HE4基因的表达,细胞增殖能力较前无明显变化,侵袭能力明显下降。结论通过增强HE4基因表达,可降低其侵袭能力,有望成为卵巢癌基因治疗的新的候选基因。 Objective To examine the effect of HE4 gene overexpression on the proliferation and invasiveness of the ovarian cancer cell line HO8910. Method HE4 carrying PcDNA3.1 vector (PcDNA3.1/HE4) was constructed and transfected into a highly metastatic human ovarian cancer cell line HO8910 with Lipofectamine 2000. The protein expression was determined by Western-blot. MTT and colony formation assay were used for cell growth measurement. Tumour cell invasiveness and cell adhesiveness were also determined. Result Overexpression of HE4 was confirmed by Western-blot and the growth was not affected by HE4 overexpression. However, the tumour cell invasiveness was reduced. Conclusion Overexpression of HE4 can reduce the invasiveness of HO8910 ceils, and HE4 may be a candidate gene for the treatment of ovarian cancer.
出处 《热带医学杂志》 CAS 2009年第6期605-607,633,共4页 Journal of Tropical Medicine
基金 国家高技术研究发展计划(863)资助项目(No.2006AA02A311) 广东省卫生厅医学科研基金(No.A2006375)
关键词 基因 HE4 卵巢肿瘤 肿瘤转移 细胞系HO8910 genes, HE4 ovarian neoplasms neoplasm metastasis cell line
  • 相关文献

参考文献12

  • 1Kirchhoff C, Habben I, Ivell R, et al. A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors [J]. Biol Reprod, 1991,45(2) :350-357.
  • 2Schummer M, Ng WV, Bumgarner RE, et al. Comparative hybridization of anarray of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas [J]. Gene, 1999,238(2) : 375-385.
  • 3Wang K, Gan L, Jeffrey E, et al. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray [J]. Gene, 1999,229( 1-2): 101-108.
  • 4Drapkin R, Vonhorsten HH, Lin Y,et al. Human epididymis protein4(HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas [J]. Cancer Res, 2005,65 (6) : 2162-2169.
  • 5Bingle L, Singleton V, Bingle CD, et al. The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms [ J]. Oncogene, 2002,21 ( 17 ) : 2768-2773.
  • 6Lu KH, Patterson AP, Wang L, et al. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis [J]. Clin Cancer Res, 2004,10(10) : 3291-3300.
  • 7Bingle L, Cross SS, High AS,et al. WFDC2(HE4):a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung [ J ]. Respir Res, 2006,7 : 61.
  • 8Galgano MT, Hampton GM, Frierson HF Jr. Comprehensive analysis of HE4 expression in normal and malignant human tissues [J]. Mod Pathol,2006, 19(6) :847-853.
  • 9Gilks CB, Vanderhyden BC, Zhu S, et al. Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling [J]. Gynecol Oncol, 2005,96 ( 3 ) : 684-694.
  • 10Peters DG,Kudla DM,Deloia JA,et al. Comparative gene expression analysis of ovarian carcinoma and normal ovarian epithelium by serial analysis of gene expression [J ]. Cancer Epidemiol Biomarkers Prey, 2005,14 (7) : 1717-1723.

同被引文献30

  • 1赵莹珺,杨剑峰,朱景德.人卵巢癌相关候选基因HE4(WFDC2)的转录调控主要由Sp1与位于-71和-48的Egr-1位点结合所介导[J].肿瘤,2004,24(6):517-525. 被引量:15
  • 2陈洁晶,吴英松,宁云山,董文其,李明.卵巢癌肿瘤标记物HE4基因的分子克隆与蛋白表达[J].热带医学杂志,2006,6(5):493-495. 被引量:10
  • 3Kirchhoff C,Habben I,Ivell R,et al.A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors.Biol Reprod,1991,45(2):350-357.
  • 4Bingle L,Singleton V,Bingle CD.The putative ovarian tumour marker gene HE4 (WFDC2),is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms.Oncogene,2002,21(17):2768-2773.
  • 5Galgano MT,Hampton GM,Frierson HF,et al.Comprehensive analysis of HE4 expression in normal and malignant human tissues.Mod Pathol,2006,19(6):847-853.
  • 6Capoccia BJ,Huh WJ,Mills JC,et al.How form follows functional genomics:gene expression profiling gastric epithelial cells with a particular discourse on the parietal cell.Physiol Genomics,2009,37(2):67-78.
  • 7Samuel WF,Cindy SM,Rhine RS,et al.Sp1 Transactivation of the TCL1 Oncogene.J Biol Chem,2003,278(2):948-955.
  • 8Sugawara A,Uruno A,Takeuchi K,et al.Transcription suppression of thromboxane receptor gene by peroxisome proliferator-activated receptor-gamma via an interaction with Sp1 in vascular smooth muscle cells.J Biol Chem,2002,277(12):9676-9683.
  • 9Schummer M,Ng WV,Bumgarner RE,et al.Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas.Gene,1999,238(2):375-385.
  • 10Hellstrom I,Raycraft J,Hayden L,et al.The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.Cancer Res,2003,63(13):3695-3700.

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部